What are the treatment options for migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Migraines

For most migraine patients, a stepped approach starting with NSAIDs as first-line treatment, followed by triptans as second-line treatment for those who don't respond to NSAIDs, is the most effective strategy for managing acute migraine attacks while minimizing risks of medication overuse headache.

First-Line Treatment Options for Acute Migraine

NSAIDs and Simple Analgesics

  • First-line treatment for mild to moderate migraines includes:
    • Ibuprofen (400-600mg)
    • Naproxen sodium (500-550mg)
    • Aspirin
    • Acetaminophen-aspirin-caffeine combination 1, 2
  • Note that acetaminophen alone is ineffective for migraine 1
  • These medications should be limited to no more than 14-15 days per month to prevent medication overuse headache 2

Second-Line Treatment Options

Migraine-Specific Medications (Triptans)

  • Indicated when NSAIDs fail or for moderate to severe migraine attacks 1, 2

  • Recommended options include:

    • Sumatriptan: 6mg subcutaneously (most rapid relief) or 50mg orally
    • Rizatriptan: 10mg orally
    • Naratriptan: oral formulation
    • Zolmitriptan: oral formulation 1, 2, 3
  • Important contraindications for triptans:

    • Uncontrolled hypertension
    • Basilar or hemiplegic migraine
    • Cardiovascular disease or risk factors
    • Concurrent use with MAO-A inhibitors 1, 2, 4
  • Safety considerations:

    • Limit triptan use to no more than 9 days per month 2
    • Monitor for serotonin syndrome when used with SSRIs or SNRIs 4
    • Be aware of potential cardiovascular events (rare but serious) 4

Alternative Second-Line Options

  • Dihydroergotamine (DHE) intranasal spray has good evidence for efficacy 1, 2
  • Butorphanol nasal spray may be considered in specific cases 1

Route of Administration Considerations

  • For patients with significant nausea or vomiting:
    • Use non-oral routes of administration 1, 2
    • Subcutaneous sumatriptan (6mg) offers most rapid relief 2
    • Intranasal formulations are also effective options 2

Rescue Medications

  • When first and second-line treatments fail, consider:
    • Opioids (with caution regarding risk of dependence)
    • Butalbital-containing compounds 1, 2
  • These should be limited to situations where other options have failed and risk of abuse has been addressed 1, 5

Preventive Treatment

Consider preventive treatment when:

  • Patient experiences ≥2 migraine attacks per month with significant disability
  • Acute treatments are used more than twice weekly 2

Preventive medication options:

  • Beta blockers (propranolol 80-240 mg/day)
  • Tricyclic antidepressants (amitriptyline 30-150 mg/day)
  • Anticonvulsants
  • CGRP monoclonal antibodies 2

Non-Pharmacological Approaches

  • Regular aerobic exercise or strength training
  • Maintaining regular sleep schedule
  • Adequate hydration
  • Identification and avoidance of triggers
  • Relaxation techniques or mindfulness 2

Important Clinical Pearls

  1. Avoid medication overuse: Limit acute treatments to prevent medication-overuse headache:

    • Triptans: no more than 9 days/month
    • NSAIDs: no more than 15 days/month 1, 2
  2. Monitor for rebound headaches: Associated with withdrawal of analgesics or abortive migraine medications, particularly with opiates, triptans, ergotamine, and medications containing caffeine, isometheptene, or butalbital 1

  3. Patient education: Encourage patients to track headache frequency, severity, duration, disability, response to treatment, and adverse effects using a headache diary 1

  4. Identify triggers: Help patients recognize factors that may trigger migraines (alcohol, caffeine, certain foods, stress, fatigue, perfumes, fumes, glare, flickering lights) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Migraine Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral sumatriptan for acute migraine.

The Cochrane database of systematic reviews, 2003

Research

Acute Migraine Headache: Treatment Strategies.

American family physician, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.